HIGHLIGHTS OF PRESCRIBING INFORMATIONThese highlights do not include all the... |

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.
THROMBIN-JMI® (thrombin, topical, bovine origin)
If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.
THROMBIN-JMI® Quick Finder
WARNING: SEVERE BLEEDING AND THROMBOSIS COMPLICATIONS
- •
- THROMBIN-JMI® can cause fatal severe bleeding or thrombosis. Thrombosis may result from the development of antibodies...
1 INDICATIONS AND USAGE
THROMBIN-JMI is topical bovine thrombin indicated to aid hemostasis whenever oozing blood and minor bleeding from capillaries and small venules is accessible and control of bleeding by standard...
2 DOSAGE AND ADMINISTRATION
For topical use on the surface of bleeding tissue only. Do not inject.
2.1 Reconstitution
- •
- ...
3 DOSAGE FORMS AND STRENGTHS
THROMBIN-JMI (Thrombin, Topical (Bovine) U.S.P.), Solution for topical use is supplied in the following packages:
Vial: 5,000 IU vial with 5 mL diluent.
Vial: 20,000 IU vial with 20...
4 CONTRAINDICATIONS
- •
- Do not inject directly into the circulatory system. Because of its action in the clotting mechanism, THROMBIN-JMI can cause extensive intravascular clotting or death.
- •
- Do not re-expose...
5 WARNINGS AND PRECAUTIONS
5.1 Hypersensitivity Reactions
- •
- Allergic reactions, including anaphylactic/...
6 ADVERSE REACTIONS
The most common adverse reactions (incidence greater than or equal to 2%) following administration of THROMBIN-JMI were: hypersensitivity, bleeding, anemia, post-operative wound infection, thromboembolic...
8 USE IN SPECIFIC POPULATIONS
8.1 Pregnancy
Risk Summary
Animal reproduction studies have not been...
11 DESCRIPTION
THROMBIN-JMI, Thrombin, Topical (Bovine), is a protein substance produced through a conversion reaction in which prothrombin of bovine origin is activated by tissue thromboplastin of bovine origin in the...
12 CLINICAL PHARMACOLOGY
12.1 Mechanism of Action
THROMBIN-JMI requires no intermediate physiological agent for its action. It activates...
13 NONCLINICAL TOXICOLOGY
13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility
No studies have been undertaken examining...
14 CLINICAL STUDIES
Observational Study
A total of 554 subjects were enrolled, in a multicenter, open-label,...
15 REFERENCES
- 1.
- Morse DC, Silva E, Bartrom J, et al: Improved bleeding scores using Gelfoam Powder with incremental concentrations of bovine thrombin in a swine liver lesion model. J Throm Thrombolysis...
16 HOW SUPPLIED/STORAGE AND HANDLING
Not made with natural rubber latex.
THROMBIN-JMI® is supplied in the following packages:
- NDC 60793-215-05
Vial: 5,000 IU vial...
17 PATIENT COUNSELING INFORMATION
Because THROMBIN-JMI may cause the formation of clots in blood vessels if absorbed systemically, advise patients to consult their physician if they experience leg tenderness or swelling,...
To report an adverse event related to a Pfizer product and you are not part of a clinical trial* for this product, click the link below to submit your information: Pfizer Safety Reporting Site
*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.
If you cannot use the above website to report an adverse event related to a Pfizer product, please call Pfizer Medical Information at (800) 438-1985.
(800)-332-1088.